SCOPE, BOUNDARY AND REPORTING CYCLE

This Annual Report and Financial Statements (“Annual Report”) of Mediclinic International plc (the “Company” or “Mediclinic”) presents the financial results, and the economic, social and environmental performance of the Mediclinic Group for the financial year ended 31 March 2017 (the “reporting period”), and covers the Company’s operations in Southern Africa, Switzerland and the United Arab Emirates (the “Group”).

REPORTING PRINCIPLES

The information in this Annual Report is deemed to be useful and relevant to our stakeholders, with due regard to our stakeholders’ expectations through continuous engagement, or that the Board believes may influence the perception or decision-making of our stakeholders. The information provided aims to provide our stakeholders with an understanding of the Group’s financial, social, environmental and economic impacts to enable them to evaluate the ability of Mediclinic to create and sustain value for our stakeholders.

This Annual Report was prepared in accordance with the International Financial Reporting Standards, the LSE Listing Rules, the JSE Listings Requirements, the UK Corporate Governance Code, and the UK Companies Act (including the recently promulgated Companies, Partnerships and Group (Accounts and Non-Financial Reporting) Regulations 2016) aimed at improving the transparency of companies regarding non-financial and diversity information, where relevant. The Company applied the majority of the principles contained in the UK Corporate Governance Code. Principles not applied are explained in the Corporate Governance Statement. The Company’s reporting on sustainable development included in this report, supplemented by the Sustainable Development Report, was done in accordance with the GRI Sustainability Reporting Standards 2016 and the Non-Financial Reporting Regulations 2016 referred to above.

EXTERNAL AUDIT AND ASSURANCE

The Company’s annual financial statements and the Group’s consolidated annual financial statements were audited by the Group’s independent external auditors, PricewaterhouseCoopers LLP, in accordance with International Standards of Auditing (UK and Ireland).

The Group follows various other voluntary external accreditation, certification and assurance initiatives, complementing the Group’s combined assurance model, as reported on in the Risk Management section. The Group believes that this adds to the transparency and reliability of information reported to our stakeholders.

GLOSSARY

Please refer to the glossary of terms used in this report.